Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Clonal heterogeneity in health and disease


Aaron Viny, MD MS
AACR (2018)
Description

Immunohistochemistry (IHC) has been the gold standard to determine if a patient is in remission but laboratories are transitioning into RT-PCR for fusions and flow cytometry for greater depth of response. However, clinicians are now moving away from algorithms to understand clonal architecture and mutation acquisition. Dr. Viny applies single-cell DNA techniques to examine clonal hematopoiesis and minimal residual disease for a better understanding as to why some mutations are chemo- sensitive and others resistant to therapy.



VIEW


Scientific presentation
Get SNVs and CNVs from the Tapestri Platform
Kelly Kaihara, PhD
Robert Durruthy-Durruthy, PhD
Nature Research (2019)
Scientific presentation
Investigation of AML clonal architecture with mutational and immunophenotypic profiling simultaneously from the same cell(s)
Linde Miles, PhD
AMP (2019)
Scientific presentation
In pursuit of the leukemic stem cell: Leveraging single-cell genomics and proteomics to identify drivers of AML
Katherine D Cummins, MD FRACP FRCPA
AMP (2019)
Scientific presentation
Single-cell sequencing reveals clonal heterogeneity in acute lymphoblastic leukemia
Jan Cools, PhD
Llucia Albert Servera, PhD
Nature Research (2019)
REQUEST QUOTE